ADVERTISEMENT

NTAGI

Cervical cancer vaccine to be in immunisation program

The CERVAVAC vaccine is likely to be launched by the Serum Institute of India (SII) in April next year

14 December 2022, 11:10 IST

Vaccine against cervical cancer to be included in national immunisation program by mid-2023: NTAGI chief

Vaccine against cervical cancer to be included in national immunisation program by mid-2023: NTAGI chief

Cervical cancer vaccine to be in immunisation program

14 December 2022, 11:10 IST

Covid-19 booster dose gap reduced to 6 months

Previously, the precautionary shot was allowed after nine months or 39 weeks

06 July 2022, 17:10 IST

Covid-19 booster dose gap reduced to 6 months for all adults

Covid-19 booster dose gap reduced to 6 months for all adults

Covid-19 booster dose gap reduced to 6 months

06 July 2022, 17:10 IST

NTAGI endorses reduction of precaution dose gap

As of now, all those above 18 years who have completed nine months after the second dose are eligible for the precaution jab

05 May 2022, 21:06 IST

NTAGI endorses precaution dose before 9-month waiting period for those travelling abroad

NTAGI endorses precaution dose before 9-month waiting period for those travelling abroad

NTAGI endorses reduction of precaution dose gap

05 May 2022, 21:06 IST

NTAGI to discuss early booster for those going abroad

The National Technical Advisory Group on Immunisation (NTAGI) may also review the data of Covid-19 vaccines for the 5-12 age group

02 May 2022, 20:14 IST

NTAGI to discuss whether to allow early administration of precaution dose to those travelling abroad

NTAGI to discuss whether to allow early administration of precaution dose to those travelling abroad

NTAGI to discuss early booster for those going abroad

02 May 2022, 20:14 IST

NTAGI recommends including Covovax for 12-17 age group

India's drug regulator had approved Covovax for restricted use in the 12-17 age group, subject to certain conditions, on March 9

29 April 2022, 14:16 IST

NTAGI panel recommends inclusion of Covovax in vaccination drive for 12-17 age group

NTAGI panel recommends inclusion of Covovax in vaccination drive for 12-17 age group

NTAGI recommends including Covovax for 12-17 age group

29 April 2022, 14:16 IST

Panel recommends including Covovax in vaccination drive

The Pune-based firm wanted to provide Covovax to private hospitals at Rs 900 per dose plus GST

03 April 2022, 12:12 IST

Govt panel recommends inclusion of Covovax in Covid vaccination drive for those aged 12 and above

Govt panel recommends inclusion of Covovax in Covid vaccination drive for those aged 12 and above

Panel recommends including Covovax in vaccination drive

03 April 2022, 12:12 IST

NTAGI recommends reducing gap between Covishield doses

The recommendation for Covishield is yet to be implemented in the national Covid-19 vaccination programme

20 March 2022, 10:33 IST

NTAGI recommends reducing gap between Covishield doses to 8-16 weeks

NTAGI recommends reducing gap between Covishield doses to 8-16 weeks

NTAGI recommends reducing gap between Covishield doses

20 March 2022, 10:33 IST

Centre orders pediatric vaccine despite efficacy doubts

Corbevax is a protein sub-unit vaccine developed in the United States and licensed to the Indian firm, Biological E Ltd (BioE) for production

13 February 2022, 22:04 IST

Centre places order for pediatric vaccine despite doubts over efficacy

Centre places order for pediatric vaccine despite doubts over efficacy

Centre orders pediatric vaccine despite efficacy doubts

13 February 2022, 22:04 IST